Biostar Pharmaceuticals, Inc. (BSPM)

Market Cap	3.00 -100.0%
Revenue (ttm)	317.79K -91.9%
Net Income	934.35K
EPS	0.34
Shares Out	2.64M
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	6,529
Open	0.0000
Previous Close	n/a
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0500
Beta	-4,884.85
RSI	47.57
Earnings Date	n/a

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 200
• Stock Exchange: OTCMKTS
• Ticker Symbol: BSPM

Financial Performance

In 2016, Biostar Pharmaceuticals's revenue was $2.38 million, a decrease of -91.21% compared to the previous year's $27.13 million. Losses were -$5.70 million, -77.31% less than in 2015.